CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Open-market sale U.S. President-Pharma Business sold 3,251 shares at $25.02 ($81,340)
- 4 Open-market sale U.S. President-Pharma Business sold 3,251 shares at $26.63 ($86,574)
- 4 Grant or award Director acquired 1,245 shares (grant or award)
- 4 Grant or award Director acquired 249 shares (grant or award)
- 4 Grant or award Director acquired 1,380 shares (grant or award)
- 4 Grant or award Director acquired 1,109 shares (grant or award)
- 4 Grant or award Director acquired 1,109 shares (grant or award)
- 4 Grant or award Director acquired 1,109 shares (grant or award)
- 4 Shares withheld for taxes CEO, Pharma Business gave up 3,461 shares (to pay taxes)
- 4 Open-market buy Director bought 60,000 shares at an average $24.23 ($1,453,524)
- 4 Grant or award SVP, Controller and CAO acquired 1,246 shares (grant or award)
- 4 Shares withheld for taxes U.S. President-Pharma Business gave up 283 shares (to pay taxes)
- 4 Grant or award Director acquired 246 shares (grant or award)
- 4 Grant or award Director acquired 1,368 shares (grant or award)
- 4 Grant or award Director acquired 1,099 shares (grant or award)
- 4 Grant or award Director acquired 1,099 shares (grant or award)
- 4 Grant or award Director acquired 1,099 shares (grant or award)
- 4 Grant or award Director acquired 1,234 shares (grant or award)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 8,559 shares (to pay taxes)
- 4 Grant or award President, Salix acquired 9,026 shares (grant or award)
Page 13 of 61 · 1,214 filings